NO905557D0 - Fremgangsmaate for fremstilling av et farmasoeytisk pulverpreparat. - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk pulverpreparat.

Info

Publication number
NO905557D0
NO905557D0 NO905557A NO905557A NO905557D0 NO 905557 D0 NO905557 D0 NO 905557D0 NO 905557 A NO905557 A NO 905557A NO 905557 A NO905557 A NO 905557A NO 905557 D0 NO905557 D0 NO 905557D0
Authority
NO
Norway
Prior art keywords
tablets
drug
powder compositions
spray dried
drying
Prior art date
Application number
NO905557A
Other languages
English (en)
Other versions
NO905557L (no
Inventor
Roy Kuramoto
Zakauddin Tanwir Chowhan
Randal Owen Pendleton
Hafez Hafezzadeh
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of NO905557D0 publication Critical patent/NO905557D0/no
Publication of NO905557L publication Critical patent/NO905557L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NO90905557A 1989-12-22 1990-12-21 Fremgangsmaate for fremstilling av et farmasoeytisk pulverpreparat. NO905557L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45510989A 1989-12-22 1989-12-22

Publications (2)

Publication Number Publication Date
NO905557D0 true NO905557D0 (no) 1990-12-21
NO905557L NO905557L (no) 1991-06-24

Family

ID=23807439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90905557A NO905557L (no) 1989-12-22 1990-12-21 Fremgangsmaate for fremstilling av et farmasoeytisk pulverpreparat.

Country Status (16)

Country Link
EP (1) EP0436373B1 (no)
JP (1) JPH05320045A (no)
KR (1) KR910011241A (no)
AT (1) ATE110267T1 (no)
AU (1) AU640725B2 (no)
CA (1) CA2032956A1 (no)
DE (1) DE69011836T2 (no)
ES (1) ES2063296T3 (no)
FI (1) FI906372A (no)
HU (1) HUT59594A (no)
IE (1) IE904666A1 (no)
IL (1) IL96749A0 (no)
NO (1) NO905557L (no)
NZ (1) NZ236631A (no)
PT (1) PT96229B (no)
ZA (1) ZA9010353B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020808A1 (en) * 1992-04-15 1993-10-28 Marion Merrell Dow Inc. Aminoguanidine spray drying process
WO1998024410A2 (en) * 1996-12-03 1998-06-11 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
DE60225560T2 (de) * 2001-07-30 2009-04-02 Dsm Ip Assets B.V. Zusammensetzung enthaltend epigallocatechin-gallat
WO2003063822A2 (en) 2002-02-01 2003-08-07 Pfizer Products Inc. Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
JP2008222567A (ja) * 2007-03-08 2008-09-25 Iwate Univ 微粒子の製造方法
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
US20190105274A1 (en) * 2015-07-13 2019-04-11 Kyowa Hakko Bio Co., Ltd. Tablets containing arginine at high concentration
JP6619644B2 (ja) * 2015-12-22 2019-12-11 アサヒグループ食品株式会社 錠剤の製造方法、及び錠剤原料用顆粒の製造方法
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
MX2022002356A (es) * 2019-08-26 2022-04-06 Dsm Ip Assets Bv Forma de dosificacion oral solida que comprende naproxeno y vitamina b12.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
ES2058288T3 (es) * 1987-07-08 1994-11-01 American Home Prod Composiciones de ibuprofen secadas por atomizacion.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.

Also Published As

Publication number Publication date
EP0436373B1 (en) 1994-08-24
ZA9010353B (en) 1992-08-26
NZ236631A (en) 1993-03-26
HUT59594A (en) 1992-06-29
HU908395D0 (en) 1991-07-29
JPH05320045A (ja) 1993-12-03
ATE110267T1 (de) 1994-09-15
DE69011836D1 (de) 1994-09-29
AU6837590A (en) 1991-06-27
EP0436373A1 (en) 1991-07-10
DE69011836T2 (de) 1995-03-09
PT96229A (pt) 1991-09-30
FI906372A0 (fi) 1990-12-21
IE904666A1 (en) 1991-07-17
CA2032956A1 (en) 1991-06-23
NO905557L (no) 1991-06-24
IL96749A0 (en) 1991-09-16
KR910011241A (ko) 1991-08-07
FI906372A (fi) 1991-06-23
ES2063296T3 (es) 1995-01-01
AU640725B2 (en) 1993-09-02
PT96229B (pt) 1998-06-30

Similar Documents

Publication Publication Date Title
NO905557L (no) Fremgangsmaate for fremstilling av et farmasoeytisk pulverpreparat.
KR880004805A (ko) 분무건조된 아세트아미노펜
DE3772072D1 (de) Pharmazeutische zusammensetzung.
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
NO863796D0 (no) Fremgangsmaate for fremstilling av farmakologiske preparater med forlenget virkningstiden.
KR910014120A (ko) 피모벤단의 경구용 약제학적 제제
KR880004803A (ko) 분무 건조된 아세트아미노펜
JPH0142923B2 (no)
JPS5474855A (en) Preparation of finely divided soluble cellulose derivative
US5534551A (en) Aminoguanidine spray drying process
CA1268706A (en) Method for simultaneously drying and granulating extract substances from deproteinized calves blood
US5185336A (en) Method for producing substantially pure vitamin powders
WO2002039980A3 (en) Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole
GB1506345A (en) Multitioned tablets
JPS557236A (en) Preparation of powdery sodium acetate (anhydrous)
MY101266A (en) Pharmaceutical formulations
RU2195286C1 (ru) Твердая лекарственная форма, содержащая глицирам
KR100679166B1 (ko) 안정성이 증진된 약제학적 조성물 및 그의 제조방법
JPS60243080A (ja) 塩酸カルボクロメン含水結晶
RU98115790A (ru) Способ получения таблеток ранитидина
KR900000075A (ko) 장용성 과립제의 제조방법
RU97106462A (ru) Способ получения таблетированной формы препарата